عنوان
پدید آورنده
موضوع
رده
کتابخانه
محل استقرار
NATIONAL BIBLIOGRAPHY NUMBER
Number
LA60k8s17c
LANGUAGE OF THE ITEM
.Language of Text, Soundtrack etc
انگلیسی
TITLE AND STATEMENT OF RESPONSIBILITY
Title Proper
Empagliflozin-induced Diabetic Ketoacidosis Unmasking a Type 1 Diabetes Diagnosis
General Material Designation
[Article]
First Statement of Responsibility
Ray, Gretchen M.; Rodriguez, Chelsea; Schulman, Samantha; Sarangarm, Preeyaporn; Bardack, Michelle; Bouchonville, Matthew F.
SUMMARY OR ABSTRACT
Text of Note
Empagliflozin is a sodium glucose cotransporter-2 inhibitor that inhibits renal glucose reabsorption through an insulin-independent mechanism. This class of drugs is used in the management of type 2 diabetes. A 49-year-old female with type 2 diabetes treated with empagliflozin presented to the emergency department in diabetic ketoacidosis (DKA). This case report details the series of events leading to the diagnosis of drug-induced DKA, which led to a change in the patient's diagnosis from type 2 diabetes to type 1 diabetes.
SET
Date of Publication
2019
Title
Clinical Practice and Cases in Emergency Medicine
Volume Number
3/2
PERSONAL NAME - PRIMARY RESPONSIBILITY
Entry Element
Ray, Gretchen M.; Rodriguez, Chelsea; Schulman, Samantha; Sarangarm, Preeyaporn; Bardack, Michelle; Bouchonville, Matthew F.
ELECTRONIC LOCATION AND ACCESS
Electronic name
مطالعه متن کتاب [Article]
275578
a
Y
